Table 5 Relationships between LMR, NLR, PLR and clinicopathologic features of 46 elderly patients
Characteristics | Total patients | LMR | NLR | PLR | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
<4 (n = 21) | ≥4 (n = 25) | p value | 1.6< (n = 12) | ≥1.6 (n = 34) | p value | 147< (n = 25) | ≥147 (n = 21) | p value | ||
Age (years) |  | 74.0 ± 3.8 | 75.4 ± 4.4 | 0.8781 | 74.3 ± 3.0 | 75.0 ± 4.5 | 0.6094 | 76.2 ± 4.3 | 73.1 ± 3.3 | 0.012 |
Gender | Â | Â | Â | 0.2226 | Â | Â | 0.453 | Â | Â | 0.2226 |
 Male | 41 | 20 | 21 |  | 10 | 31 |  | 21 | 20 |  |
 Female | 5 | 1 | 4 |  | 2 | 3 |  | 4 | 1 |  |
WBC |  | 5715.7 ± 1976.4 | 5596.0 ± 1891.6 | 0.835 | 4512.5 ± 1281.2 | 6052.4 ± 1946.8 | 0.0146 | 6080.0 ± 1881.6 | 5139.5 ± 1858.8 | 0.0966 |
 Neutrophil |  | 3790.0 ± 1932.6 | 3195.8 ± 1346.0 | 0.2271 | 2169.4 ± 828.4 | 3925.1 ± 1626.7 | 0.0009 | 3570.0 ± 1424.7 | 3344.5 ± 1909.4 | 0.649 |
 Lymphocyte |  | 1258.9 ± 352.0 | 1892.1 ± 593.0 | <0.0001 | 1822.8 ± 528.1 | 1525.4 ± 594.0 | 0.1327 | 1943.9 ± 555.2 | 1197.2 ± 294.4 | <0.0001 |
 Monocyte |  | 490.2 ± 174.3 | 311.6 ± 115.0 | 0.0001 | 344.1 ± 158.3 | 410.5 ± 171.8 | 0.2469 | 375.1 ± 164.4 | 414.7 ± 176.4 | 0.4351 |
Platelet |  | 250.0 ± 85.7 | 212.8 ± 54.3 | 0.0805 | 263.8 ± 92.6 | 217.8 ± 60.4 | 0.0563 | 198.8 ± 53.8 | 266.6 ± 74.7 | 0.0009 |
Location of tumor | Â | Â | Â | 0.6568 | Â | Â | 0.1274 | Â | Â | 0.2753 |
 Ce | 2 | 1 | 1 |  | 1 | 1 |  | 0 | 2 |  |
 Ut | 4 | 1 | 3 |  | 0 | 4 |  | 2 | 2 |  |
 Mt | 16 | 6 | 10 |  | 6 | 10 |  | 8 | 8 |  |
 Lt | 21 | 12 | 9 |  | 3 | 18 |  | 12 | 9 |  |
 Ae | 3 | 1 | 2 |  | 2 | 1 |  | 3 | 0 |  |
Tumor size (mm) |  | 4.9 ± 1.5 | 3.9 ± 2.5 | 0.0987 | 4.6 ± 3.2 | 4.3 ± 1.7 | 0.6459 | 3.9 ± 1.8 | 4.9 ± 2.4 | 0.0987 |
Depth of tumor | Â | Â | Â | 0.0716 | Â | Â | 0.3997 | Â | Â | 0.2032 |
 T1a-1b | 22 | 8 | 14 |  | 5 | 17 |  | 11 | 11 |  |
 2 | 6 | 1 | 5 |  | 3 | 3 |  | 5 | 1 |  |
 3 | 16 | 10 | 6 |  | 3 | 13 |  | 9 | 7 |  |
 4a-4b | 2 | 2 | 0 |  | 1 | 1 |  | 0 | 2 |  |
Lymph node metastasis | Â | Â | Â | 0.1229 | Â | Â | 0.2441 | Â | Â | 0.0875 |
 N0 | 23 | 8 | 15 |  | 4 | 19 |  | 11 | 12 |  |
 N1 | 14 | 6 | 8 |  | 6 | 8 |  | 9 | 5 |  |
 N2 | 6 | 4 | 2 |  | 2 | 4 |  | 5 | 1 |  |
 N3 | 3 | 3 | 0 |  | 0 | 3 |  | 0 | 3 |  |
Pathological stage | Â | Â | Â | 0.0825 | Â | Â | 0.3939 | Â | Â | 0.8129 |
 1a-1b | 18 | 5 | 13 |  | 3 | 15 |  | 9 | 9 |  |
 2a-2b | 13 | 6 | 7 |  | 5 | 8 |  | 8 | 5 |  |
 3a-3c | 15 | 10 | 5 |  | 4 | 11 |  | 8 | 7 |  |
Operation time (min) |  | 700.0 ± 187.8 | 656.8 ± 185.7 | 0.4385 | 682.3 ± 227.8 | 674.5 ± 172.6 | 0.9021 | 668.5 ± 154.0 | 686.2 ± 221.6 | 0.7515 |
Intraoperative blood loss (ml) |  | 800.7 ± 718.7 | 681.5 ± 840.3 | 0.3057 | 469.8 ± 368.8 | 829.9 ± 866.8 | 0.1723 | 675.2 ± 818.5 | 808.2 ± 746.9 | 0.2854 |
SCC antigen |  | 1.56 ± 1.44 | 0.96 ± 0.68 | 0.0342 | 0.90 ± 0.80 | 1.35 ± 1.21 | 0.2379 | 1.07 ± 0.78 | 1.42 ± 1.43 | 0.2961 |